These results suggest that FOXQ1 overexpression in CRC cells can promote tumor angiogenesis either by promoting secretion of tumor cell-produced angiogenic factors mainly in the EGF/PDGF pathway, while reducing the expression of angiogenic inhibitors (Figure 5). Here, EGF is linked to neoplasm.